Provided by Tiger Trade Technology Pte. Ltd.

Ovid Therapeutics Inc.

2.69
+0.05502.09%
Volume:693.61K
Turnover:1.85M
Market Cap:523.58M
PE:-10.59
High:2.73
Open:2.69
Low:2.64
Close:2.63
52wk High:3.11
52wk Low:1.12
Shares:195.00M
Float Shares:163.00M
Volume Ratio:0.58
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2535
EPS(LYR):-0.2325
ROE:-25.96%
ROA:-23.46%
PB:2.49
PE(LYR):-11.55

Loading ...

Regulatory Timing Risks Mount for Ovid Therapeutics as FDA Funding and Staffing Volatility Threaten Drug Approval Timelines

TIPRANKS
·
Mar 20

BUZZ-U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies

Reuters
·
Mar 19

Exchange-Traded Funds, Equity Futures Lower Ahead of Key Economic Data, FOMC Meeting

MT Newswires Live
·
Mar 18

BUZZ-U.S. STOCKS ON THE MOVE-Tencent, Air Products, Protagonist

Reuters
·
Mar 18

Ovid Therapeutics publishes corporate presentation on OV329 and OV4071 pipeline updates

Reuters
·
Mar 18

BRIEF-Ovid Therapeutics Announces New Ov329 Data And Indication Expansion, Phase 1 Clearance For Ov4071, And Reports Fourth Quarter And Full Year 2025 Financial Results

Reuters
·
Mar 18

BRIEF-Ovid Therapeutics Announces Pricing Of $60 Million Private Placement

Reuters
·
Mar 18

Ovid Therapeutics Shares Rise After Swinging to 4Q Profit, Expanding Treatment

Dow Jones
·
Mar 18

Ovid Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 18

Ovid Therapeutics Shares up 26.4% Premarket After Positive Safety Data for Experimental Epilepsy Drug

THOMSON REUTERS
·
Mar 18

BUZZ-Ovid Therapeutics rises as epilepsy drug shows clean safety

Reuters
·
Mar 18

Ovid Therapeutics Q4 net income hits USD 9.7 million as revenue jumps more than doubled to USD 0.7 million

Reuters
·
Mar 18

Ovid Therapeutics Inc - Reports $90.4 Mln in Cash, Cash Equivalents and Marketable Securities as of Dec 31, 2025

THOMSON REUTERS
·
Mar 18

Ovid Therapeutics prices USD 60 million private placement

Reuters
·
Mar 18

Press Release: Ovid Therapeutics Announces Pricing of $60 Million Private Placement

Dow Jones
·
Mar 18